genetically modified organism

• 遺伝子組換え体

関

transgenic organism

WordNet

1. a living thing that has (or can develop) the ability to act or function independently (同)being
2. a system considered analogous in structure or function to a living body; "the social organism"
3. changed in form or character; "their modified stand made the issue more acceptable"; "the performance of the modified aircraft was much improved"
4. by genetic mechanisms; "genetically passed down talents"

PrepTutorEJDIC

1. 有機体,生物 / (国家・社会などの)有機的組織体

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/10/19 05:44:49」(JST)

wiki en

[Wiki en表示]

"GMO" redirects here. For other uses, see GMO (disambiguation).

For related content, see genetically modified food, genetically modified crops, and genetic engineering.

GloFish, the first genetically modified animal to be sold as a pet

A genetically modified organism (GMO), also known as a transgenic organism, is any organism whose genetic material has been altered using genetic engineering techniques (i.e. genetically engineered organism). GMOs are the source of medicines and genetically modified foods and are also widely used in scientific research and to produce other goods.The term GMO is very close to the technical legal term, 'living modified organism', defined in the Cartagena Protocol on Biosafety, which regulates international trade in living GMOs (specifically, "any living organism that possesses a novel combination of genetic material obtained through the use of modern biotechnology").

Production

Further information: genetic engineering, genetic modification, horizontal gene transfer, molecular cloning, recombinant DNA and transformation (genetics)

Genetic modification involves the mutation, insertion, or deletion of genes. Inserted genes usually come from a different species in a form of horizontal gene-transfer. In nature this can occur when exogenous DNA penetrates the cell membrane for any reason. To do this artificially may require:

• attaching the genes to a virus
• physically inserting the extra DNA into the nucleus of the intended host with a very small syringe
• with the use of electroporation (that is, introducing DNA from one organism into the cell of another by use of an electric pulse)
• with very small particles fired from a gene gun.

Other methods exploit natural forms of gene transfer, such as the ability of Agrobacterium to transfer genetic material to plants, or the ability of lentiviruses to transfer genes to animal cells.

History

Main article: History of genetic engineering

Humans have domesticated plants and animals since around 12,000 BCE, using selective breeding or artificial selection (as contrasted with natural selection). The process of selective breeding, in which organisms with desired traits (and thus with the desired genes) are used to breed the next generation and organisms lacking the trait are not bred, is a precursor to the modern concept of genetic modification. When nucleic acid sequences are combined in a laboratory, the resulting DNA is called recombinant DNA. Recombinant DNA may contain oligonucleotides from the same or similar species, in which case it is called "cisgenic", or may contain oligonucleotides from different organisms that could not naturally interbreed, in which case it is called "transgenic". Recombinant DNA may also contain synthetic sequences.

The first recombinant DNA molecules were produced by Paul Berg in 1972. Genetic engineering, the direct manipulation of genes using biotechnology, was first accomplished by Herbert Boyer and Stanley Cohen in 1973. Whereas selective breeding depends on naturally occurring genetic variation within a population or species, genetic engineering can involve the intentional introduction of genes from different species. Advances have allowed scientists to manipulate, remove, and add genes to a variety of different organisms to induce a range of different traits. From 1976 the technology became commercialized, with companies producing and selling genetically modified foods and medicines.

Uses

GMOs are used in biological and medical research, production of pharmaceutical drugs, experimental medicine (e.g. gene therapy), and agriculture (e.g. golden rice, resistance to herbicides). The term "genetically modified organism" does not always imply, but can include, targeted insertions of genes from one species into another. For example, a gene from a jellyfish, encoding a fluorescent protein called GFP, or green fluorescent protein, can be physically linked and thus co-expressed with mammalian genes to identify the location of the protein encoded by the GFP-tagged gene in the mammalian cell. Such methods are useful tools for biologists in many areas of research, including those who study the mechanisms of human and other diseases or fundamental biological processes in eukaryotic or prokaryotic cells.

Microbes

Bacteria were the first organisms to be modified in the laboratory, due to their simple genetics.

They continue to be important model organisms for experiments in genetic engineering. In the field of synthetic biology, they have been used to test various synthetic approaches, from synthesizing genomes to creating novel nucleotides.

These organisms are now used for several purposes, and are particularly important in producing large amounts of pure human proteins for use in medicine.

Genetically modified bacteria are used to produce the protein insulin to treat diabetes. Similar bacteria have been used to produce biofuels, clotting factors to treat haemophilia, and human growth hormone to treat various forms of dwarfism.

In addition, various genetically engineered micro-organisms are routinely used as sources of enzymes for the manufacture of a variety of processed foods. These include alpha-amylase from bacteria, which converts starch to simple sugars, chymosin from bacteria or fungi, which clots milk protein for cheese making, and pectinesterase from fungi, which improves fruit juice clarity.

Plants

Transgenic plants

Kenyans examining insect-resistant transgenic Bt corn

Transgenic plants have been engineered for scientific research, to create new colours in plants, and to create different crops.

In research, plants are engineered to help discover the functions of certain genes. One way to do this is to knock out the gene of interest and see what phenotype develops. Another strategy is to attach the gene to a strong promoter and see what happens when it is over expressed. A common technique used to find out where the gene is expressed is to attach it to GUS or a similar reporter gene that allows visualisation of the location.'

Suntory "blue" rose

After thirteen years of collaborative research, an Australian company – Florigene, and a Japanese company – Suntory, created a blue rose (actually lavender or mauve) in 2004. The genetic engineering involved three alterations – adding two genes, and interfering with another. One of the added genes was for the blue plant pigment delphinidin cloned from the pansy. The researchers then used RNA interference (RNAi) technology to depress all color production by endogenous genes by blocking a crucial protein in color production, called dihydroflavonol 4-reductase) (DFR), and adding a variant of that protein that would not be blocked by the RNAi but that would allow the delphinidin to work. The roses are sold in Japan, the United States, and Canada. Florigene has also created and sells lavender-colored carnations that are genetically engineered in a similar way.

Simple plants and plant cells have been genetically engineered for production of biopharmaceuticals in bioreactors as opposed to cultivating plants in open fields. Work has been done with duckweed Lemna minor, the algae Chlamydomonas reinhardtii and the moss Physcomitrella patens. An Israeli company, Protalix, has developed a method to produce therapeutics in cultured transgenic carrot and tobacco cells. Protalix and its partner, Pfizer, received FDA approval to market its drug Elelyso, a treatment for Gaucher's disease, in 2012.

Genetically modified crops

Main article: Genetically modified crops

Genetically modified crops (GM crops, or biotech crops) are plants used in agriculture, the DNA of which has been modified using genetic engineering techniques. In most cases the aim is to introduce a new trait to the plant which does not occur naturally in the species. Examples in food crops include resistance to certain pests, diseases, or environmental conditions, reduction of spoilage, or resistance to chemical treatments (e.g. resistance to a herbicide), or improving the nutrient profile of the crop. Examples in non-food crops include production of pharmaceutical agents, biofuels, and other industrially useful goods, as well as for bioremediation.

Farmers have widely adopted GM technology. Between 1996 and 2013, the total surface area of land cultivated with GM crops increased by a factor of 100, from 17,000 square kilometers (4,200,000 acres) to 1,750,000 km² (432 million acres). 10% of the world's croplands were planted with GM crops in 2010. In the US, by 2014, 94% of the planted area of soybeans, 96% of cotton and 93% of corn were genetically modified varieties. In recent years GM crops expanded rapidly in developing countries. In 2013 approximately 18 million farmers grew 54% of worldwide GM crops in developing countries.

For discussions of issues about GM crops and GM food, see the Controversies section below and the article on genetically modified food controversies.

Cisgenic plants

Cisgenesis, sometimes also called intragenesis, is a product designation for a category of genetically engineered plants. A variety of classification schemes have been proposed that order genetically modified organisms based on the nature of introduced genotypical changes rather than the process of genetic engineering.

While some genetically modified plants are developed by the introduction of a gene originating from distant, sexually incompatible species into the host genome, cisgenic plants contain genes that have been isolated either directly from the host species or from sexually compatible species. The new genes are introduced using recombinant DNA methods and gene transfer. Some scientists hope that the approval process of cisgenic plants might be simpler than that of proper transgenics, but it remains to be seen.

Mammals

Some chimeras, like the blotched mouse shown, are created through genetic modification techniques like gene targeting.

Genetically modified mammals are an important category of genetically modified organisms. Ralph L. Brinster and Richard Palmiter developed the techniques responsible for transgenic mice, rats, rabbits, sheep, and pigs in the early 1980s, and established many of the first transgenic models of human disease, including the first carcinoma caused by a transgene. The process of genetically engineering animals is a slow, tedious, and expensive process. However, new technologies are making genetic modifications easier and more precise.

The first transgenic (genetically modified) animal was produced by injecting DNA into mouse embryos then implanting the embryos in female mice.

Genetically modified animals currently being developed can be placed into six different broad classes based on the intended purpose of the genetic modification:

1. to research human diseases (for example, to develop animal models for these diseases);
2. to produce industrial or consumer products (fibres for multiple uses);
3. to produce products intended for human therapeutic use (pharmaceutical products or tissue for implantation);
4. to enrich or enhance the animals' interactions with humans (hypo-allergenic pets);
5. to enhance production or food quality traits (faster growing fish, pigs that digest food more efficiently);
6. to improve animal health (disease resistance)

Research use

Dolly was a female domestic sheep and the first animal to be cloned from an adult somatic cell

Transgenic animals are used as experimental models to perform phenotypic and for testing in biomedical research.

Genetically modified (genetically engineered) animals are becoming more vital to the discovery and development of cures and treatments for many serious diseases. By altering the DNA or transferring DNA to an animal, we can develop certain proteins that may be used in medical treatment. Stable expressions of human proteins have been developed in many animals, including sheep, pigs, and rats. Human-alpha-1-antitrypsin, which has been tested in sheep and is used in treating humans with this deficiency and transgenic pigs with human-histo-compatibility have been studied in the hopes that the organs will be suitable for transplant with less chances of rejection.

Scientists have genetically engineered several organisms, including some mammals, to include green fluorescent protein (GFP), first observed in the jellyfish, Aequorea victoria in 1962, for medical research purposes (Chalfie, Shimoura, and Tsien were awarded the Nobel prize in Chemistry in 2008 for the discovery and development of GFP ). For example, fluorescent pigs have been bred to study human organ transplants (xenotransplantation), regenerating ocular photoreceptor cells, and other topics. In 2011 a Japanese-American team created green-fluorescent cats to find therapies for HIV/AIDS and other diseases as feline immunodeficiency virus (FIV) is related to HIV.

In 2009, scientists in Japan announced that they had successfully transferred a gene into a primate species (marmosets) and produced a stable line of breeding transgenic primates for the first time. Their first research target for these marmosets was Parkinson's disease, but they were also considering amyotrophic lateral sclerosis and Huntington's disease.

Producing human therapeutics

Within the field known as pharming, intensive research has been conducted to develop transgenic animals that produce biotherapeutics. On 6 February 2009, the U.S. Food and Drug Administration approved the first human biological drug produced from such an animal, a goat. The drug, ATryn, is an anticoagulant which reduces the probability of blood clots during surgery or childbirth. It is extracted from the goat's milk.

Production or food quality traits

In 2006, a pig was engineered to produce omega-3 fatty acids through the expression of a roundworm gene.

Enviropig was a genetically enhanced line of Yorkshire pigs in Canada created with the capability of digesting plant phosphorus more efficiently than conventional Yorkshire pigs. The project ended in 2012. These pigs produced the enzyme phytase, which breaks down the indigestible phosphorus, in their saliva. The enzyme was introduced into the pig chromosome by pronuclear microinjection. With this enzyme, the animal is able to digest cereal grain phosphorus. The use of these pigs would reduce the potential of water pollution since they excrete from 30 to 70.7% less phosphorus in manure depending upon the age and diet. The lower concentrations of phosphorus in surface runoff reduces algal growth, because phosphorus is the limiting nutrient for algae. Because algae consume large amounts of oxygen, it can result in dead zones for fish.

In 2011, Chinese scientists generated dairy cows genetically engineered with genes from human beings to produce milk that would be the same as human breast milk. This could potentially benefit mothers who cannot produce breast milk but want their children to have breast milk rather than formula. Aside from milk production, the researchers claim these transgenic cows to be identical to regular cows. Two months later scientists from Argentina presented Rosita, a transgenic cow incorporating two human genes, to produce milk with similar properties as human breast milk. In 2012, researchers from New Zealand also developed a genetically engineered cow that produced allergy-free milk.

Goats have been genetically engineered to produce milk with strong spiderweb-like silk proteins in their milk.

Human gene therapy

Gene therapy, uses genetically modified viruses to deliver genes that can cure disease in humans. Although gene therapy is still relatively new, it has had some successes. It has been used to treat genetic disorders such as severe combined immunodeficiency, and Leber's congenital amaurosis. Treatments are also being developed for a range of other currently incurable diseases, such as cystic fibrosis, sickle cell anemia, Parkinson's disease, cancer, diabetes, heart disease and muscular dystrophy.

Fish

Genetically modified fish are used for scientific research and as pets, and are being considered for use as food and as aquatic pollution sensors.

GM fish are widely used in basic research in genetics and development. Two species of fish, zebrafish and medaka, are most commonly modified because they have optically clear chorions (membranes in the egg), rapidly develop, and the 1-cell embryo is easy to see and microinject with transgenic DNA.

The GloFish is a patented brand of genetically modified (GM) fluorescent zebrafish with bright red, green, and orange fluorescent color. Although not originally developed for the ornamental fish trade, it became the first genetically modified animal to become publicly available as a pet when it was introduced for sale in 2003. They were quickly banned for sale in California.

GM fish have been developed with promoters driving an over-production of "all fish" growth hormone for use in the aquaculture industry to increase the speed of development and potentially reduce fishing pressure on wild stocks. This has resulted in dramatic growth enhancement in several species, including salmon, trout and tilapia. AquaBounty Technologies, a biotechnology company working on bringing a GM salmon to market, claims that their GM AquAdvantage salmon can mature in half the time as wild salmon. AquaBounty has applied for regulatory approval to market their GM salmon in the US. As of December 2012 the application was still pending. On 25 November 2013 Canada approved commercial scale production and export of GM Salmon eggs but they are not approved for human consumption in Canada.

Several academic groups have been developing GM zebrafish to detect aquatic pollution. The lab that originated the GloFish discussed above originally developed them to change color in the presence of pollutants, to be used as environmental sensors. A lab at University of Cincinnati has been developing GM zebrafish for the same purpose, as has a lab at Tulane University.

Recent research on pain in fish has resulted in concerns being raised that genetic-modifications induced for scientific research may have detrimental effects on the welfare of fish.

Invertebrates

Fruit flies

In biological research, transgenic fruit flies (Drosophila melanogaster) are model organisms used to study the effects of genetic changes on development. Fruit flies are often preferred over other animals due to their short life cycle, low maintenance requirements, and relatively simple genome compared to many vertebrates.

Mosquitoes

In 2010, scientists created "malaria-resistant mosquitoes" in the laboratory. The World Health Organization estimated that malaria killed almost one million people in 2008. Genetically modified male mosquitoes containing a lethal gene have been developed to combat the spread of dengue fever. Aedes aegypti mosquitoes, the single most important carrier of dengue fever, were reduced by 80% in a 2010 trial of these GM mosquitoes in the Cayman Islands. Between 50 and 100 million people are affected by dengue fever every year and 40,000 people die from it.

Bollworms

A strain of Pectinophora gossypiella (Pink bollworm) has been genetically engineered to express a red fluorescent protein. This allows researchers to monitor bollworms that have been sterilized by radiation and released to reduce bollworm infestation. The strain has been field tested for over three years and has been approved for release.

Cnidarians

Cnidarians such as Hydra and the sea anemone Nematostella vectensis have become attractive model organisms to study the evolution of immunity and certain developmental processes. An important technical breakthrough was the development of procedures for generation of stably transgenic hydras and sea anemones by embryo microinjection.

Regulation

Main articles: Regulation of genetic engineering and Regulation of the release of genetically modified organisms

The regulation of genetic engineering concerns the approaches taken by governments to assess and manage the risks associated with the use of genetic engineering technology and the development and release of genetically modified organisms (GMO), including genetically modified crops and genetically modified fish. There are differences in the regulation of GMOs between countries, with some of the most marked differences occurring between the USA and Europe. Regulation varies in a given country depending on the intended use of the products of the genetic engineering. For example, a crop not intended for food use is generally not reviewed by authorities responsible for food safety. The European Union differentiates between approval for cultivation within the EU and approval for import and processing. While only a few GMOs have been approved for cultivation in the EU a number of GMOs have been approved for import and processing. The cultivation of GMOs has triggered a debate about coexistence of GM and nonGM crops. Depending on the coexistence regulations, incentives for cultivation of GM crops differ.

Controversy

Main article: Genetically modified food controversies

There is controversy over GMOs, especially with regard to their use in producing food. The dispute involves buyers, biotechnology companies, governmental regulators, non-governmental organizations, and scientists. The key areas of controversy related to GMO food are whether GM food should be labeled, the role of government regulators, the effect of GM crops on health and the environment, the effect on pesticide resistance, the impact of GM crops for farmers, and the role of GM crops in feeding the world population. In 2014, sales of products which had been labeled as non-GMO grew 30 percent to $1.1 billion.

There is a general scientific agreement that food from genetically modified crops is not inherently riskier to human health than conventional food. No reports of ill effects have been proven in the human population from ingesting GM food. Although labeling of GMO products in the marketplace is required in many countries, it is not required in the United States and no distinction between marketed GMO and non-GMO foods is recognized by the US FDA. In a May 2014 article in The Economist it was argued that, while GM foods could potentially help feed 842 million malnourished people globally, laws such as those being considered by Vermont's governor, Peter Shumlin, to require labeling of foods containing genetically modified ingredients, could have the unintended consequence of interrupting the benign process of spreading GM technologies to impoverished countries that suffer with food security problems.

The Organic Consumers Association, and the Union of Concerned Scientists, and Greenpeace stated that risks have not been adequately identified and managed, and they have questioned the objectivity of regulatory authorities. Some health groups say there are unanswered questions regarding the potential long-term impact on human health from food derived from GMOs, and propose mandatory labeling or a moratorium on such products. Concerns include contamination of the non-genetically modified food supply, effects of GMOs on the environment and nature, the rigor of the regulatory process, and consolidation of control of the food supply in companies that make and sell GMOs.

See also

• BioSteel
• Chimera (genetics)
• Council for Responsible Genetics
• Detection of genetically modified organisms
• Gene flow
• Gene pool
• Genetic erosion
• Horizontal gene transfer
• Non-GMO Project
• Organic farming
• Reading Scientific Services (detecting GMOs)
• SMART breeding
• Sperm-mediated gene transfer
• Timeline of genetically modified organisms

References

External links

• Everything you wanted to know about GM organisms — Provided by New Scientist.
• Transgenic Organism Research
• International Society for Transgenic Technologies (ISTT)
• GMO-Compass: Information on genetically modified organisms
• Co-Extra: Research on co-existence and traceability of GM and non-GM supply chains
• ISAAA Knowledge Center: Information on genetically modified organisms

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. メンデル遺伝の概要 overview of mendelian inheritance
• 2. ノカルジア症の臨床症状および診断 clinical manifestations and diagnosis of nocardiosis
• 3. 成人の家族性高コレステロール血症：概要 familial hypercholesterolemia in adults overview
• 4. 先天性魚鱗癬の概要と分類 overview and classification of the inherited ichthyoses
• 5. 胎児機能評価 the fetal biophysical profile

English Journal

• An overview of algae biofuel production and potential environmental impact.

• Menetrez MY.SourceOffice of Research and Development, National Risk Management Research Laboratory, Air Pollution Prevention and Control Division, U.S. Environmental Protection Agency , Research Triangle Park, North Carolina 27711, United States.
• Environmental science & technology.Environ Sci Technol.2012 Jul 3;46(13):7073-85. Epub 2012 Jun 20.
• Algae are among the most potentially significant sources of sustainable biofuels in the future of renewable energy. A feedstock with virtually unlimited applicability, algae can metabolize various waste streams (e.g., municipal wastewater, carbon dioxide from industrial flue gas) and produce product
• PMID 22681590

• Evaluation of plasmid and genomic DNA calibrants used for the quantification of genetically modified organisms.

• Caprioara-Buda M, Meyer W, Jeynov B, Corbisier P, Trapmann S, Emons H.SourceEuropean Commission, Joint Research Centre, Institute for Reference Materials and Measurements (IRMM), Retieseweg 111, 2440, Geel, Belgium.
• Analytical and bioanalytical chemistry.Anal Bioanal Chem.2012 Jul;404(1):29-42. Epub 2012 May 26.
• The reliable quantification of genetically modified organisms (GMOs) by real-time PCR requires, besides thoroughly validated quantitative detection methods, sustainable calibration systems. The latter establishes the anchor points for the measured value and the measurement unit, respectively. In thi
• PMID 22638881

Japanese Journal

• 遺伝子組換え（耐熱性α-アミラーゼ産生）トウモロコシ3272に適したDNA抽出法の検討および系統特異的定量検知法の開発と性能評価

• 食品衛生学雑誌 57(1), 1-6, 2016
• NAID 130005131600

• DNAマイクロアレイによる遺伝子組換え作物の品種同定検査法

• 日本食品化学学会誌 22(2), 133-138, 2015-08-26
• NAID 110009987553

• 長野県松本地域で販売されたダイズ製品における組換えダイズ混入状況の網羅的調査結果

• 日本食品化学学会誌 22(2), 123-132, 2015-08-26
• NAID 110009987552

Related Links

• genetically modified organism - definition of genetically ...

ge·net·i·cal·ly modified organism (j-n t-k-l) n. Abbr. GMO An organism whose genetic characteristics have been altered by the insertion of a modified gene or a ... ANKARA, Jan 21, 2010 (TUR) -- Turkish Agriculture & Rural Affairs ...

• Genetically Modified Organisms (GMO): - Bacillus thuringiensis

Genetically Modified Organisms (GMO): When a gene from one organism is purposely moved to improve or change another organism in a laboratory, the result is a genetically modified organism (GMO). It is also ...

Related Pictures

---

★リンクテーブル★

リンク元	「transgenic organism」
関連記事	「organism」「genetically modified」「genetically」

「transgenic organism」

　　[★]

• 形質転換体、遺伝子組換え体

関

genetically modified organism、transformant

「organism」

　　[★]

• n.

• 生物、生命体、生物体

関

biologic、biological、biotic、flesh

　 　 　

「genetically modified」

　　[★]

• 遺伝子改変の

関

genetically altered、genetically engineered

「genetically」

　　[★]

• 遺伝的に

関

genetic、heritable、heritably